Clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel has an effective and acceptable safety and tolerability profile for the treatment of acne vulgaris in Japanese patients: a phase III, multicentre, randomised, single-blinded, active-controlled, parallel-group study.

CONCLUSION: Compared with CLNP-BID, CLNP/BPO 3%-QD was more effective and CLNP/BPO 3%-BID at least as effective, with an early onset of action and an acceptable safety and tolerability profile in Japanese patients. This article is protected by copyright. All rights reserved.
PMID: 25040180 [PubMed - as supplied by publisher]

Source: The British Journal of Dermatology - July 12, 2014 Category: Dermatology Authors: Kawashima M, Hashimoto H, Alió Sáenz AB, Ono M, Yamada M Tags: Br J Dermatol Source Type: research